is the observation that Andean and Tibetan high-altitude natives exhibit similar exercise capacities at high altitude (3900 m) even though Andean natives often present with a higher percent haematocrit (Hct) when compared with both lowland natives and Tibetans. The current review summarizes past literature that has examined the effect of RCV changes on maximal exercise capacity at moderate to high altitudes, and discusses the explanation elucidating these seemingly paradoxical observations.
Introduction
The study of both acclimatization and adaptation to hypoxia in humans is a timely topic of current research. Approximately 16.5 million km 2 of the earth's surface exists at or above an elevation of 2000 m. [1] More importantly, between 140 and 150 million people reside at these high altitudes, while another 35 million lowland dwellers visit or commute to elevations above 3000 m annually. [2, 3] Exposure of humans to such altitudes is a challenge to homeostatic maintenance of oxygen flux as a result of the gradual decrease in the partial pressure of oxygen (PO 2 ) attendant to the diminishing barometric pressure. [4] Our understanding regarding the physiological importance of red blood cell volume (RCV) at high altitudes is important, as the erythrocyte is the primary means of transporting oxygen from the environment to respiring cells. In this review, RCV is referring to the total number of erythrocytes in the blood as opposed to the volume of individual red blood cells. Research examining this area of interest has presented seemingly conflicting results.
The overall aims of this review are to (i) review maximal exercise capacity near sea level (0-500 m) and the effect of increasing RCV in these conditions; (ii) introduce the topic of study regarding the function of RCV and exercise capacity at elevations ranging in between 2000 and 5500 m; (iii) summarize the literature that has studied the role of RCV manipulation on the ability to exercise at elevations ranging from moderate to high altitude; and (iv) discuss these seemingly paradoxical observations.
The initial set of studies included in the review were retrieved through a search of PubMed and Web of Science using the keywords 'acclimatization', 'exercise', 'high altitude', 'percent haematocrit' and 'red blood cell'. Only those studies that had corresponding measurements of exercise performance with percent haematocrit (Hct), total haemoglobin (Hb) mass, or total arterial oxygen content (CaO 2 ) at baseline, and following an intervention (e.g. acclimatization to a given altitude, haemodilution, blood infusion or erythropoietin [EPO] administration) fulfilled our criteria, and were selected. Preferable studies were those that had measurements for either Hct, or total Hb mass in conjunction with CaO 2 . From those primary studies, we established both forward and backward reference mapping for potential studies of interest that were initially missed through the database searches. Again, studies of interest were examined, and only those that met the previous selection criteria were included in this review. Overall, 20 studies fit our criteria and have been included in this review (see tables).
This topic has been presented in several independent studies, but to the best of our knowledge never collectively in a publication that assembles and interprets all relevant literature together. In this way, the present review shall contribute to our understanding of the actual impact of RCV and attendant CaO 2 on exercise capacity at altitude. In our effort, we attempt to cover the whole spectrum of RCV manipulations including acclimatization, acute reductions (haemodilution), acute expansions (transfusion) and, finally, more chronic expansion of RCV (via an erythropoiesisstimulating agent [ESA] ), and how these manipulations affect exercise at moderate to high altitude. The limitation of this review is the lack of data dealing with exercise capacity in polycythaemic highlanders prior to, and following, haemodilution. This may be of interest for future research.
The Relationship between Oxygen Transport and Exercise Capacity from Sea Level to Higher Elevations
Exercise capacity at sea level tightly correlates with RCV. [5] The fact that an individual's aptitude for exercise, both maximally [6] [7] [8] [9] [10] [11] [12] and/or submaximally, [6, 7, 9, 11, 13] improves near sea level following increases in RCV is well understood. [14] This improvement in exercise performance is mostly a direct result of the increase in CaO 2 that is concomitant to increases in RCV. [8] [9] [10] [15] [16] [17] Alternative means of adjusting CaO 2 , such as hyperoxic breathing, increases exercise performance not only at sea level but also at higher elevations; [18, 19] although the added bulk of equipment necessary for oxygen supplementation is not conducive for most exercising athletes. Interestingly, there is evidence suggesting that hyperoxic breathing may be more advantageous when attempting to improve maximal oxygen consumption ( . VO 2max ) than methods used to increase RCV such as blood transfusions or treatment with an ESA. The ratio of change (D) in . VO 2max per DCaO 2 appears greater with hyperoxic breathing (2.06) [18, 19] when compared with increases in RCV (0.70) [8] [9] [10] [11] 17] at sea level. Maximal workload has also been shown to significantly increase (233 -15 W to 283 -18 W) after acclimatization to 5260 m when increasing hyperoxic breathing from 21% to 55% oxygen independent of any change in leg . VO 2max . [20] Future studies manipulating RCV, and the partial pressure of arterial oxygen (PaO 2 ), while maintaining CaO 2 will help to clarify the ratelimiting mechanism(s) of maximal exercise in various environments. The limited evidence suggests that diffusion limitations at the level of the skeletal muscle, even at sea level, may be greater than previously assumed, though they are easily overshadowed by convective limitations of oxygen transport. While convective limitations in oxygen delivery have dominated scientific dogma in regards to our understanding of a physiological bottlenecklimiting exercise capacity, it is important to acknowledge and identify diffusive limitations of oxygen flux that occur as well. For instance, in some fit to elite athletes a pulmonary limitation exists during exercise at sea level. [21] [22] [23] Ventilation-perfusion inequality and alveolar-end-capillary oxygen diffusion limitation increase along with exercise intensity [24] [25] [26] resulting in exerciseinduced arterial hypoxaemia (EIAH). EIAH is defined as a drop in arterial oxygen saturation (SaO 2 ) ranging from 95% (mild) to less than 88% (severe). [27, 28] The degree of EIAH positively correlates with training status and has been observed at both maximal [29] and submaximal exercise intensities. [22, 23] Individuals that display EIAH during sea-level exercise exhibit a more profound reduction in . VO 2max at elevations above sea level that is apparent even when going to a low altitude of 1000 m. Conversely, individuals that maintain SaO 2 during maximal exertion at sea level experience negligible decrements in . VO 2max with an equivalent 1000 m increase in elevation. [30] Hitherto, the principal factors limiting the maximal capacity for exercise at sea level has largely been attributed to the convective limitations of oxygen transport as opposed to the diffusive limitations at any point from the environment to the mitochondria, namely the lung and skeletal muscle. [16, [31] [32] [33] This concept has been tested and challenged in regards to exercise performance at higher elevations.
Optimal Haematocrit for Exercise Performance
The rheological properties of blood throughout the vascular network are not static and fluctuate according to vessel diameter. Hct and viscosity both decrease with diminishing vessel diameter, known as the Fahraeus effect [34] and the FahraeusLindqvist effect, [35] respectively. Accordingly, capillary Hct is significantly lower than systemic Hct. [36] An additional mechanism responsible for Hct heterogeneity in the microcirculation is the unequal division of red cell and plasma volumes at arterial bifurcations. This uneven separation, referred to as plasma skimming, with the daughter branch receiving a greater proportion of blood flow, also results in a disproportionately high distribution of erythrocytes. [37] [38] [39] How these phenomena influence oxygen diffusion in the tissue, especially at moderate to high altitude, is unknown.
Discussion of blood characteristics in this review refer to those measured in relatively large systemic vessels.
The optimal Hct for exercise performance is the Hct at which exercise capacity is maximized. Near sea level, the optimal Hct has been proposed to occur when CaO 2 and cardiac output are collectively the greatest. [40] [41] [42] [43] The first study to ascertain an actual optimal Hct for both sea level . VO 2max and endurance capacities (time to exhaustion; TTE) in vivo, established that the relationship between the exercise capacity and Hct in a mouse model is parabolic; [44] exercise capacity improves with increasing Hct to a point where further increases begin to hinder maximal exercise capabilities (figure 1) due to increasing viscosity of the blood. The optimal Hct for maximal performance was observed at 57% and 68% depending on the acute or chronic presence of EPO in the animal's circulation. [44] At higher elevations (i.e. 3800 m), optimal Hct is theorized to occur as the mixed venous partial pressure of oxygen (PvO 2 ), in respect to Hb concentration ([Hb]), is maximized. [45] At an elevation of 4724 m, the heart rate of subjects was shown to decrease as Hct increased from 46% to 59%, and then reciprocally increase as Hct subsequently fell during stable submaximal exercise with the lowest submaximal heart rate occurring at an Hct of 59%. While these observations were indicative that increased Hct improved submaximal exercise performance, the value of 59% was never confirmed as an optimal Hct. [46] The theoretical constructs of an optimal Hct for exercise performance has been discussed in the past [7, 20, [40] [41] [42] 45, 47, 48] although this had never been directly measured in humans.
During exercise Hct may increase. Exercise induced haemoconcentration in humans occurs primarily from a transient shift of fluid from intravascular to extravascular compartments concomitant to increased blood flow, capillary perfusion and increased filtration of both cutaneous and muscle capillary beds, [49] but also to the slight contribution of erythrocytes from adrenergicstimulated splenic contraction [50, 51] and fluid loss through sweat with prolonged exercise. Unlike athletically endowed animals, such as the dog and horse, who can increase Hct (25-50%) during exercise by splenic contraction thus allowing for an increase in . VO 2max (10-30%), [52] exercise induced haemoconcentration in humans is small but significant with Hct increasing around 4-6%, [50, 51] and both arterial [Hb] and oxygen carrying capacity improving by approximately 10%. [53, 54] As mentioned above the optimal Hct for maximizing exercise performance near sea level was found to be approximately 58% in ESA-treated wild-type mice. [44] Whether or not this value is transferable to humans is unknown, but this Hct far exceeds normal Hct in healthy males/females at rest (40-45%/ 37-42%) and during exercise (45-50%/42-47%).
One past gold medal winning Olympic athlete possessed an autosomal dominant mutation in the EPO receptor that led to increased sensitivity of erythroid progenitors to EPO, and constitutively elevated [Hb] (231 g/L) and an Hct (68%) similar to the optimal Hct detected in mice that constitutively overexpress EPO. This athlete displayed an exceptional aptitude for exercise together with such haematological parameters. [55] This heightened [Hb] corresponds to an estimated CaO 2 at sea level of 30 mL of oxygen per dL of blood opposed to the approximate 20 mL/dL, given that this athlete possessed a more common value of [Hb], 15 dL/mL, which precipitates . Fig. 1 . Relationship between maximal aerobic consumption and percent haematocrit in wild type mice following either injection with erythropoietic stimulating agent or blood withdrawal. Adapted from Schuler et al., [44] with permission. Hct = haematocrit; . VO 2max = maximal oxygen consumption.
roughly a 67% increase in locomotor oxygen delivery during exercise.
Apart from genetic disorders, the optimal Hct for exercise in mice at sea level is much closer to the Hct following acclimatization to high altitude that, dependent on elevation, can reach values ranging from 50% to 55% or above. [20, [56] [57] [58] [59] Nevertheless, the extent to which increases in RCV and, more importantly, the attendant increases in CaO 2 have on exercise performance at varying degrees of altitude above sea level, still remains unclear.
Acclimatization and Red Blood Cell Volume (RCV)
Although hypoxia-induced erythropoiesis is highlighted in this discussion, it is important to keep in mind that acclimatization to elevations ranging from low to extreme altitude is an exceptionally complex and integrative process that is still being studied. In addition to erythropoiesis, [59, 60] acclimatization includes, but is not limited to, alteration in ventilation and gas exchange, [61] [62] [63] [64] [65] cardiovascular and haemodynamic function, [66, 67] autonomic outflow [68, 69] skeletal muscle morphology and biochemical expression, [70] [71] [72] [73] [74] [75] neuroendocrine regulation, [76] and nutrient partitioning. [77] All these observable changes following acclimatization collectively modify physiological homeostasis, as well as one's capacity for exercise. Accordingly, the aim of this review is to provide new insights into the role of RCV on performance at moderate to high altitude and the underlying mechanism(s) attributable to the measured outcomes. This is important, seeing as how the relevant studies summarized in this review have utilized hypobaric hypoxia, [46] acute hypoxic breathing [15, 16, 40, 47, 78, 79] and experimentation at actual altitude; [20, [56] [57] [58] [80] [81] [82] [83] the majority of studies investigate different severities and lengths of exposure to the respective altitude or degree of hypoxia which, very understandably, lead to different physiological effects.
Acclimatization is commonly believed to be associated with an increase in RCV, although not all high-dwelling mammals express this phenotype. Measurements in high-altitude dwelling animals, such as the llama, [84] and high-altitude natives including the Tibetans [85] and Ethiopians, [86] all showing values of total Hb mass and Hct that are closer to values observed in lowlanders at sea level, have led some to question the importance of hypoxia-induced erythropoiesis. [20, 56] The llama's RCV is more elliptical than disc shaped resulting in more viscous whole blood at a given Hct. [41] For this reason, high-altitude dwelling llamas understandably have lower Hct when compared with humans residing at the same elevation. Differences in Hct between high-altitude native populations are not so clearly understood.
Discordantly to both Ethiopians and Tibetans, Andean natives express an Hct significantly above sea-level values. [62, 85, 87, 88] Recent evidence reveals that the gene encoding for hypoxia-inducible factor (HIF)-2a, EPAS1, [89] represents a key gene mutation explaining some of the differences to adapting and living at high altitudes among different native populations. [90] [91] [92] [93] Tibetan and Andean natives exhibit similar maximal exercise capacities at 3900 m despite significantly greater CaO 2 , [Hb] and Hct in the Andean population. [94] The maintenance of exercise capacity despite different haematological parameters may be explained by the gene mutation in HIF-2a observed in Tibetans. [90] [91] [92] [93] It has been speculated that EPO-induced erythropoiesis has not evolved to cope with high-altitude exposure, but to keep a balanced red blood cell production at or near sea level. Consequently, it has been suggested that most humans are designed to live at or near sea level. [90] Comparisons of rheological properties between high-altitude populations have not been examined. The influence of hypoxia on the biophysical properties of erythrocytes and whole blood is unclear. Hypoxia influenced haemorheological adaptations differ between species, [95] [96] [97] as well as within species. [97] [98] [99] [100] [101] It appears that animals and humans susceptible to the development of high-altitude illness have a more pronounced response (i.e. increase in blood viscosity and/or loss of erythrocyte deformability). [97, 98, 100, 101] Accordingly, a complete examination into the differences in haemorheological compensation between Tibetans, Ethiopians and Andeans is merited.
Aside from intergenetic variability between native high-altitude populations, the majority of humans experience some degree of erythropoietic activation when exposed to a hypoxic environment. [59] This expansion in RCV occurs slowly over time in lowlanders sojourning to high altitude. As the availability of oxygen decreases, humans undergo some degree of RCV expansion through activation of erythropoietic precursor cells in bone marrow via EPO, [102] which is primarily expressed by the kidneys. As our understanding of the mechanisms that upregulate EPO, mediated by HIF-2a [103, 104] has improved, the physiological significance for this increase in RCV remains incomplete.
What is the Relationship between RCV and Exercise from Low to High Altitudes?
The general concept of improving the capacity for exercise at altitude via an increase in RCV is simple. Exercise performance declines linearly from approximately 300 m to 3000 m [105] with an average decline in . VO 2max of 6.4% for every 750 m. [80, 105, 106] The loss of exercise capacity is even greater at elevations of 3000 m and above. [107] Maximal sea-level exercise capacity is directly related to CaO 2 . [14] Thus it seems quite plausible to hypothesize that the loss of exercise capacity at altitude could be offset if CaO 2 was increased via an infusion or upregulation of RCV. Clearly this supposition is not entirely true. While several studies have demonstrated a benefit of higher total Hb mass and Hct on an individual's capacity for exercise at elevations above 2000 m, [16, 40, 46, 47, 57, 58, 83] others have reported negligible effects. [16, 20, 56, 78, 80, 81] These studies will be discussed in more detail in sections 6 and 7. Theoretical computation estimated the value of [Hb] and Hct to be between 15 g/dL and 18 g/dL, and 45% and 54%, respectively, in order to optimize CaO 2 and oxygen utilization at an elevation of 3800 m. [45] An optimal Hct in humans or animals has never been directly determined at elevations above 500 m.
Published findings relating the change in exercise capacity following acclimatization to elevations above 2000 m have been seemingly inconsistent. When comparing exercise capacity at elevations above sea level, both before and then following acclimatization, . VO 2max has been shown to increase at 2300 m, [108, 109] 3800 m [110] and 4300 m, [57] but not after acclimatization to 3475 m, [111] 4100 m [112, 113] and 4300 m. [77, 114, 115] Regardless, if exercise capacity does improve pre-to post-acclimatization, it never returns to sea-level values. [82, 116, 117] 
Acclimatization and Maximal Exercise Capacity at Moderate to High Altitudes
The following studies have specifically monitored changes in Hct, [Hb] , and/or CaO 2 in parallel with an evaluation of exercise over time, while remaining at a respective altitude. Table I summarizes the data from such studies that have investigated changes in Hct, [Hb] , and/or CaO 2 alongside measurements of exercise capacity comparing an initial/early versus a more chronic exposure to a particular elevation. Some studies have demonstrated a benefit to exercise capacity following acclimatization. Four weeks at 2270 m increased Hct by 7.2% and absolute . VO 2max by 5.6% above values collected 2 days after exposure to this moderate altitude. [118] When comparing 1 versus 16 days acclimatization to 4300 m, Hct, CaO 2 and relative . VO 2max increased by 12.7%, 18.5% and 9.9%, respectively. [57] Additionally, . VO 2max increased subsequent to acclimatization at 4300 m despite no change in maximal cardiac output. [57] When Hct and CaO 2 were then lowered by 10.6% and 8.8%, respectively via isovolaemic haemodilution, . VO 2max was also reduced by 8.2%. [57] When compared with acute hypoxic exposure, lowland natives acclimatized to 5260 m demonstrated a 31.3% increase in CaO 2 attendant to a 30.4% increase in [Hb] both of which corresponded to a 13% increase in absolute . VO 2max . [83] With the uncertainty concerning RCV, exercise capacity and well-being at higher elevations, the identification of a 'normal' Hct value in high-altitude natives was sought. Subjects volunteering for this study were residents of and around La Paz, Bolivia (approximately 3700 m), and were classified as anaemic, normal or polycythaemic, dependent upon Hct that averaged 42%, 54% and 65%, respectively. [58] Exercise tests were administered to normal and anaemic subjects. The 28.6% higher average Hct in normal subjects corresponded to a 26.9% greater average 
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Pugh, [118] ( [57] (1980) Tufts et al., [58] (1985) [120] (1990) [58] Unfortunately, the exercise capacity for those that presented with polycythaemia could not be measured.
Certain sporting events, such as the 1968 summer Olympics in Mexico City, are held at moderate to high altitudes. Exercise or sport performance that require repetitive and strenuous skeletal muscle contraction lasting 2 minutes or more are hindered by a limitation in oxygen availability. [123, 124] Spending time at the respective elevation prior to competition helps to minimize a decrement in performance. Two to 3 weeks at 2300 m improved long-distance running and swimming performance at moderate altitude. [109] Contrarily, too much time spent at high elevations may consequently diminish overall exercise performance. [124] Thus, Schuler et al. [82] examined the minimum time at moderate altitude necessary to maximize exercise performance. The most dramatic increases in exercise performance ( . VO 2max , maximal power output and TTE) occurred following 14 days at 2340 m. Additionally, all facets of exercise improvement strongly correlated with the measured changes in Hct and CaO 2 . When compared with the first day of arrival, a 10.4% increase in Hct and 11.5% improvement in CaO 2 associated with an increase in absolute . VO 2max (8.2%; figure 2a), maximal power output (8.9%; figure 2b) and TTE (12.0%; figure 2c), [82] all of which suggest a benefit of an increase in Hct and oxygen carrying capacity on exercise performance at moderate altitude.
Other studies failed to verify an improvement in exercise capacity following acclimatization and change in RCV. Compared with acute hypoxic exposure, 15-17 days at 4300 m led to an increase of [Hb] by 20.3% and CaO 2 by 29.2%, but failed to increase . VO 2max . [119] Three weeks at 5200 m increased both Hct and [Hb], but did not improve relative . VO 2max values (non-significant increase of 4.1%). [120] Unexpectedly, however, when Hct was then decreased by 2.3% via oral administration of an isomolar solution, . VO 2max significantly decreased by 7.3%. [120] At 5050 m, when comparing 1 week with 5 weeks of altitude exposure, an 8.0% increase in [Hb] corresponded to a non-significant increase in absolute . VO 2max of 13.2%. [121] Lastly, despite an 11.3% larger total Hb mass following 6 months of intermittent acclimatization to 3500 m, no differences in highaltitude . VO 2max were observed when comparing lowland controls with subjects exposed to intermittent hypoxia. [122] Acclimatization of lowlanders to a respective elevation was thought to lessen the loss of . VO 2max to values above those obtained during acute hypoxic exposure. [125] Summarization of the literature fails to verify this belief; however, the loss of exercise capacity, as well as the ability to improve following acclimatization, appears to be dependent upon the elevation. Other studies have manipulated RCV directly, either in the presence or absence of acclimatization, while also monitoring the attendant changes to exercise capacity.
Artificial Manipulation of RCV and Maximal Exercise Capacity at Moderate to High Altitude
Examining the role of RCV on exercise capacity at altitude has also been studied by direct manipulation. Decreasing RCV through the means of haemodilution, as was previously mentioned in section 6, [57, 120] and/or increasing RCV through various means aside from natural acclimatization such as direct infusion of blood [40, 47, 80] or by administration of an ESA, [16, 78] have all been examined. The effect on exercise capacity at altitude following either a decrease or an increase in RCV will be presented categorically dependent upon means of RCV augmentation.
Haemodilution and Maximal Exercise Capacity
To emphasize the uncertainties regarding the role of RCV on exercise capacity at altitude, several studies have examined changes to exercise capacity at altitude following haemodilution. The basis for such experiments was derived from the difference between the theoretical estimation of 47% as the optimal Hct for human blood [41] opposed to Hct values actually measured in both high-altitude natives (Aymara) and lowlanders acclimatized to high altitudes that are typically greater than 50%. [20, [56] [57] [58] It is hypothesized that for some given Hct, the associated blood viscosity will negate any benefit of enhanced CaO 2 due to a loss of cardiac capacity; [41, 43] although such a value has never been identified. Transgenic mice that constitutively overexpress EPO (Tg6) and , [82] with permission. Hct = percent haematocrit; TTE = time to exhaustion;
. VO 2max = maximal oxygen consumption; W = Watts. present with a high Hct of 75-91% adapt several mechanisms that help to maintain normal function despite excessive erythropoiesis and attendant blood viscosity. These mechanisms include increased erythrocyte flexibility and increased plasma nitric oxide synthase levels. [126] [127] [128] [129] Whether or not humans display similar adaptations with high Hct is unknown. Since an optimal Hct for exercise at different elevations has yet to be identified, some studies have examined the effect of increasing RCV, while others have attempted the opposite and decreased an already elevated RCV. Table II summarizes the results of such studies.
Haemodilution in one polycythaemic subject at 4250 m decreased Hct from 62% to 42% (D-32.3%). [56] Although . VO 2max was not reported, isovolaemic haemodilution increased heart rate, stroke volume, cardiac output, breathing frequency, oxygen consumption ( . VO 2 ) and respiratory exchange ratio at an absolute workload of 49 W; [56] each change suggestive of a loss in exercise capacity. The authors suggested otherwise by stating that the ventilatory breakpoint improved following haemodilution supporting the idea that a decline in RCV improved exercise performance at 4250 m. [56] The diffusive capacity of oxygen in skeletal muscle (DmO 2 ) in hypoxia (fraction of inspired oxygen [FiO 2 ] of 12%) was later examined following isovolaemic haemodilution. The replacement of 526 mL of blood with saline effectively reduced [Hb] and CaO 2 by 13.2% and 8.8%, respectively. [79] These reductions resulted in a loss of . VO 2max of approximately 13.5% in addition to a decrease in DmO 2 .
[79] The capacity to perform dynamic two-legged knee extensor exercise was examined after decreasing Hct (20.9%) and CaO 2 (18.9%) during hypoxic (FiO 2 of 11%) exercise. Peak . VO 2 values diminished by 19.4%. [15] The correlation between limb blood flow and CaO 2 was significant (r = 0.99), whereas the relationship between blood flow and PaO 2 was not. [15] One litre of blood replaced with dextran 70 following 9 weeks of acclimatization to 5260 m [20] decreased both Hct (25.0%) and CaO 2 (23.2%) with no change in . VO 2max . [20] Blood viscosity has an important role in haemodynamic control and though blood viscosity was not measured in the latter study, nor any other studies mentioned in this section, an increase in plasma viscosity by means of viscogenic plasma expanders may help to maintain vasomotor tone and microvascular function despite reductions in oxygen delivery. [130] This can play a part as to why . VO 2max failed to decrease following a loss of oxygen carrying capacity at high altitude.
Blood Transfusions and Maximal Exercise Capacity
Summarized results for studies examining the effect of RCV infusion on exercise capacity at elevations above sea level are illustrated in table III. Initial studies reported a positive effect of RCV manipulation through acute infusions. In 1945, Lieutenant Pace and colleagues [46] pioneered the first study that examined the effect of RCV manipulation and the response on exercise capacity at 4724 m using a hypobaric chamber. This classic study investigated the effect of a 3-4 day, 2000 mL RCV transfusion (50% suspension) on heart rate during submaximal exercise performance at this simulated altitude. The transfusion of RCV significantly increased Hct and CaO 2 by approximately 28% and 23%, respectively, which significantly lowered heart rates during submaximal exercise compared with those infused with an equal volume of saline. The authors suggested that an expansion in RCV via blood transfusion improves exercise tolerance in hypoxia. [46] A blood infusion consisting of 525 mL of packed RCV increased Hct by 26.6% and improved . VO 2max by 13.0% in subjects who were subjected to an acute bout of hypoxia (FiO 2 of 13.5%) simulating 3566 m. [47] Building upon initial findings, an autologous infusion of 334 mL of packed erythrocytes increased Hct by 17.8% and improved . VO 2max by 10.2% in subjects who were also subjected to an acute bout of hypoxia (FiO 2 of 16%) simulating 2255 m. [40] Later studies challenged such an effect. A blood infusion consisting of 295 mL of packed RCV significantly increased [Hb] by approximately 9%; however, it failed to increase either CaO 2 or . VO 2max within 10-14 hours of arriving at 4300 m. [80] The RCV-infused subjects were reported to have an average . VO 2max that was 230 mL/min above Horstman et al., [57] (1980) Winslow et al., [56] (1985) [120] (1990) [79] (1993) [15] (1999) [20] (2002) [47] (1982) Robertson et al., [12] (1984) saline-infused controls (reported as a trend, no p-value provided). [80] Two possible explanations for these findings are (i) out of three studies, the only one to suggest that RCV infusion doesn't increase exercise capacity at elevations above sea level infused the smallest amount of RCV and was the only study to fail in improving CaO 2 ; [80] or (ii) RCV infusion is effective in improving exercise capacity during acute hypoxic exposures simulating 3566 and 2255 m, [40, 47] but not at higher elevations such as 4300 m [80] because of a limitation in oxygen diffusion.
Erythropoiesis Stimulating Agents and Maximal Exercise Capacity
The most recent means of expanding RCV in an attempt to improve exercise capacity at altitude consists of treatment with an ESA, which has ostensibly replaced the use of blood transfusions. The results of these studies are summarized in table IV. It should be noted that the physiological effects of EPO extend beyond haematological parameters. [131] Whether a non-erythroid effect of EPO improves exercise capacity is currently under investigation. There is evidence to suggest, however, that near sea level the effects of both low-dose, long-term EPO administration on . VO 2max is dependent solely on haematological changes, [10, 132] and that there is even a greater improvement of submaximal versus maximal exercise performance. [11] The principle study to have examined the effect of RCV manipulation via an ESA on exercise performance in acute hypoxia (FiO 2 of 12.4%) used weekly subcutaneous injections of novel erythropoiesis stimulating protein (NESP) that increased Hct and CaO 2 by 16.7% and 11.6%, respectively. [78] Despite increases to both Hct and CaO 2 , . VO 2max was not affected (D0%) at the simulated elevation of 4100 m. [78] The first and only study to analyse the effect of equivalent changes in RCV on exercise capacity when exposed to different degrees of hypoxia also used ESA for RCV manipulation. [16] The results of the study are summarized in table V. Briefly, 5 weeks of treatment with recombinant human Table IV . Summary of studies that have examined the effect of erythropoietic stimulating agent on exercise capacity in a hypoxic environment Lundby et al., [78] Robach et al., [16] [16] Taken together, all the studies that utilized acute manipulations of RCV indicate that from 1500 m to somewhere between 3500 and 4500 m, greater RCV improves . VO 2max during acute exposure to hypoxia. However, at some point between elevations of 3500 and 4500 m, any assistance to exercise capacity via greater RCV is seemingly lost.
Exercise Capacity at Moderate to High Altitude with Changes in Blood and Plasma Volume
Total blood volume is comprised predominantly of RCV and plasma volume. Although this review focuses on the effect of RCV changes on exercise capacity at moderate to high altitudes, plasma volume also changes at such elevations and merits reference. Ascent to higher elevations incurs a fairly rapid (4 hours) loss of plasma volume (approximately 20%) that persists while at altitude. [59, 117, [133] [134] [135] [136] [137] The loss results, at least transiently, in a reduction in total blood volume. Hypoxic ventilatory drive increases respiration, and ultimately reduces plasma volume. Insensible water loss increases linearly with ventilation, as does excess carbon dioxide (CO 2 ) expiration, alkalosis, which is then offset by renal bicarbonate excretion and diuresis. [138] The loss of plasma assists with haemoconcentration of the blood so Hct increases independently from erythropoiesis (that increases RCV population over several weeks). This plasma loss partially accounts for the initial weight loss and the drop in cardiac filling pressures of the heart at altitude, [139, 140] but has little if any effect on maximal exercise capacity. [141] After 9 weeks of acclimatization to 5260 m, plasma and total blood volume were decreased from sea-level values, and though an infusion of 1 litre 6% dextran increased total blood volume from an average of 5.40 L to 6.32 L, maximal exercise capacity failed to improve at high altitude when compared with pre-infusion values. [117] Alternatively, after approximately 18 days of exposure to high/extreme altitude (7 days at 4350 m followed by 10-12 days at a simulated 6000 m), resting plasma volume, but not total blood volume (p = 0.06), was decreased from sea-level values by 25.8% (3.68 -0.51 L at sea level to 2.73 -0.63 L at altitude) and an infusion of 219 -22 mL of hesteril 6% improved maximal exercise capacity by 9% while at 6000 m. [137] Supplemental CO 2 (3.77%) during 5 days of simulated hypobaric hypoxia prevented haemoconcentration and maintained body weight suggesting the maintenance of plasma volumes. [142] Despite maintenance of plasma volume, exercise capacity still diminished by 33% (3.10-2.08 L/min), which was even more than the 29% decrease in subjects exposed to just hypobaric hypoxia without supplemental CO 2 (3.19-2.26 L/min). [142] There was a greater loss of exercise capacity despite no detected loss of stroke volume in the subjects supplemented with CO 2 , while it decreased in those without supplementation. [142] Arterial oxygen tension was the only variable significantly different between the two groups, and served as the best explanation for the differences in exercise capacity highlighting the importance of PaO 2 on the rate of oxygen diffusion and exercise capacity in hypoxic conditions.
The indifference of plasma volume on exercise capacity at increasing altitudes is clear, as plasma volume expansion fails to consistently improve exercise capacity or maximal cardiac output at moderate to extreme altitude [117, 134, 137] when acute supplementation of 50-100% O 2 restores Table V . Changes in haematopoietic characteristics and maximal oxygen consumption at various degrees of hypoxic exposure (reproduced from Robach et al., [16] with permission) maximal heart rate, [143] work capacity, [143, 144] maximal power output and leg . VO 2 [20, 117] to near sea-level values independent from changes in plasma or total blood volume. This also emphasizes the importance of oxygen tension and carrying capacity on exercise performance at moderate to high altitude.
Convective versus Diffusive Limitations of Oxygen Transport during Exercise at Elevations Above Sea Level
The principal limitation to exercise capacity near sea level is understood to be primarily a result of the convective restraints in oxygen transport such as cardiac output and CaO 2 . [31, 54, 145] The improvement in exercise capacity at sea level following an increase in RCV, and more importantly CaO 2 , becomes less prominent as elevation increases. As elevation increases, the primary limiting factor of exercise capacity shifts to an insufficient oxygen gradient in which the ability to drive oxygen diffusion progressively diminishes, i.e. a loss of driving pressure or a diffusive limitation to oxygen transport occurring, particularly in the lung and skeletal muscle. [146] A pressure gradient is the driving force that facilitates oxygen diffusion from the environment to the lungs, the lungs to circulating Hb within the RCV and, finally, from Hb to the metabolic machinery of the cell. The loss of environmental or ambient oxygen pressure results in the decrement of driving pressure throughout the entire cascade of oxygen transport.
By ascending to elevations above sea level, the progressive decrease in pressure gradient reduces the rate of oxygen diffusion, ultimately limiting oxygen flux and constraining maximal cellular respiration capacities. At high to extreme altitudes, the diffusive limitations of oxygen offset any increase in oxygen carrying capacity via erythrocyte infusion, EPO administration or even acclimatization. Opposingly, and further underscoring the limitation in pressure gradient at high to extreme altitude, restoring arterial oxygen tension to sealevel values re-establishes maximal power output and maximal leg . VO 2 values to those observed at sea level. [20] The phenomenon where the driving pressures of oxygen diffusion becomes limiting, which then alters exercise performance, is referred to as the 'critical PO 2 '. More specifically, the critical PO 2 is the theoretical value of arterial oxygen tension where maximal oxygen diffusion becomes restricted and results in a loss of exercise capacity. The critical PO 2 for maximal and submaximal exercise performance appear to differ; [147, 148] although identification of an actual critical PO 2 is lacking. The value has been estimated to occur somewhere from 3500 m to elevations above 4000 m, [16, 78, 149] elevations that result in a PaO 2 value of less than or equal to 40 mmHg, [150] or at elevations where SaO 2 falls to a value ranging from 70% to 75% and below. [151] Diminishing PO 2 concomitant to increasing elevations results in increased diffusion limitations that are particularly apparent in the lung, [143, [152] [153] [154] [155] skeletal muscle [113, 153, 156] and, although not yet directly measured, is suggested to play a larger role on central nervous system (CNS) oxygenation at high to extreme altitudes, more so than the loss of CaO 2 . [151] A loss of exercise capacity in hypoxia may be explained by a change in fatigue pattern from peripheral to central mechanisms. [157] The transport of oxygen from the environment to the mitochondria is dependent upon both the capacity to carry oxygen to the metabolically active tissue, as well as the pressure difference to facilitate diffusion to the respiring organelle. Maximal oxidative phosphorylation capacity of the vastus lateralis in highly trained cyclists was identified as the strongest determinant of exercise performance at 1020 m. [158] At moderate to high altitudes, an increase in RCV enhances the total capacity to carry oxygen but its effects on the rate of oxygen diffusion to respiring cells are small to negligible. [156] At altitudes corresponding to or above the critical PO 2 , the declining PO 2 results in diffusion limitations from the environment into the body, e.g. pulmonary, as well as with oxygen unloading to tissues throughout the body, independent of increases in CaO 2 , and thus limiting maximal oxygen capacity. [118, 138, 153] Exercise itself exacerbates altitude-induced hypoxaemia, as alveolar to arterial PO 2 difference (A-aDO 2 ) is linearly related to exercise intensity.
Arterial hypoxaemia is primarily attributed to an excessive exercise-induced widening of the A-aDO 2 in which the hyperventilatory response fails to sufficiently compensate. The effect of the exerciseinduced widening of A-aDO 2 becomes more prominent as elevation increases. [23] Exercise-induced A-aDO 2 widening strains systemic buffering capacity, as bicarbonate supplementation abates EIAH. [159] Exercise in combination with the loss of ambient oxygen tension at higher altitudes worsens the limitations of oxygen diffusion in the lungs, lowering PaO 2 , reducing SaO 2 , as well as attendant CaO 2 , and ultimately attenuating oxygen delivery to all tissue. Overall, the loss of diffusion gradient at the critical PO 2 counteract those attributed to a greater convective transport of oxygen, such as greater CaO 2 , resulting in negligible changes in maximal exercise capacity. [138] Diffusion limitations help to explain the seemingly paradoxical effect of a diminished exercise capacity following acclimatization to high altitudes despite large increases in RCV and attendant CaO 2 that exceed values measured at sea level. [20] Not one study that utilized acute means of RCV manipulation demonstrated an increase in . VO 2max following an increase in RCV above elevations of 3600 m. [16, 78, 80] Studies that examined acclimatization as a means of increasing RCV and changes in exercise capacity differ from the studies that utilized acute methods of RCV manipulation. Above elevations of 3600 m, increases in RCV sometimes correlated to an improvement in . VO 2max [57, 58, 83] and at other times did not. [119] [120] [121] The critical PO 2 is undoubtedly a dynamic rather than static phenomenon and fluctuates with acclimatization. Diffusive capacity of oxygen does appear to improve following acclimatization, [65] as shown by improvements in PaO 2 and SaO 2 , [83, 114] smaller A-aDO 2 gradient, [83, 160, 161] greater arteriovenous oxygen difference (a-v O 2 ) [83, 119] and an improved ratio of minute ventilation (V E ) to . VO 2 at a given workload. [62] The seemingly inconsistent correlations between RCV and . VO 2max following acclimatization may also be attributed to 'noise' associated with different tests of maximal exercise used across studies (table I) . Individual values of . VO 2max fluctuate according to subject characteristics such as degree of acclimatization to the respective elevation, training status, body mass, body composition, age and gender. [162] In well trained subjects, the loss of . VO 2max when subjected to the same absolute increase in elevation exhibits a broad interindividual variability. [30, 105] The level of training varied greatly among subjects across studies (table I) . None of the studies provided data detailing subject training or activity level while exposed to their respective elevations. The studies that monitored changes in Hct, [Hb] , and/or CaO 2 alongside exercise performance while remaining at a specific altitude (extending from 2270 to 5260 m) used varying spans of time (ranging from 2 to 10 weeks) [table I]. The possibility of confounding factors due to training or detraining adaptations should be considered with these results and accounted for in future studies.
In general, the data suggests that at elevations in which the critical PO 2 has not been met, maximal exercise is primarily limited via properties of oxygen convection, and an increase in CaO 2 would correlate with concomitant improvements in maximal exercise capacity. One of the most common mechanisms used to increase CaO 2 , and the most viable for enhancing exercise, is by increasing RCV.
Conclusions
This review elucidates the role of RCV on performance at altitude and the underlying mechanism(s) attributable to the measured outcomes. At 500-3500 m, convective limitations in oxygen transport primarily govern maximal exercise capacity, and increases in RCV and CaO 2 result in greater . VO 2max . Alternatively, at 4500 m and higher, the decrease in the partial pressure gradient of oxygen attendant to an increasing elevation leads to a loss of both driving pressure and rate of oxygen diffusion at the lung as well as the metabolic tissue, ultimately limiting cellular . VO 2 and . VO 2max . At high to extreme altitudes, RCV and any attendant increases in CaO 2 have less influence on exercise capacity when compared with lower elevations. This explains the seemingly paradoxical findings of how RCV and . VO 2max do not correlate at elevations ranging from high(er) to extreme altitudes (approximately 3500-4500 m and above). In between 3500 and 4500 m exists a critical PO 2 ; a theoretical value of arterial oxygen tension where maximal oxygen diffusion becomes restricted, resulting in a loss of exercise capacity. The critical PO 2 is dependent upon acclimatization, gender and individual training status. Future research shall attempt to elucidate limitations in oxygen transport and pinpoint a critical PO 2 by manipulating RCV and PaO 2 while maintaining CaO 2 to explain oxygen flux limitations during maximal exercise in various environments.
